儿科影像与脑肿瘤风险关联证据增加
Evidence Grows for Link Between Imaging and Brain Tumor Risk in Kids
一项涉及370多万儿童和青少年的回顾性队列研究发现,放射性医疗影像与儿童脑肿瘤风险呈剂量相关增加。累积剂量与脑肿瘤风险总体相关,每100 mGy累积剂量的超额相对风险为1.27。研究强调在临床合理的情况下使用优化协议以最小化剂量。
研究发现儿科医疗影像与脑肿瘤风险相关,但强调不应单独用于家庭咨询。
— However, findings "should not be used alone when counseling families," experts say
November 19, 2026 • 4 min read
- In a retrospective cohort study involving over 3.7 million children and adolescents, medical imaging with ionizing radiation was linked to a dose-related increase in brain tumor risk.
- Cumulative dose was associated with brain tumor risk overall, with an excess relative risk per 100 mGy of 1.27.
- There was an estimated excess risk of 7.9 tumors per 10,000 children at a dose range comparable to one head CT exam.
Medical imaging with ionizing radiation was associated with a dose-related increase in brain tumor risk among children and adolescents, a retrospective cohort study suggested.
Compared with no exposure, brain tumor risk increased with cumulative radiation dose, with hazard ratios of 1.12 (95% CI 1.01-1.26) for the lowest exposure category (>0 to <1 mGy) to 3.85 (95% CI 2.43-5.75) for the highest category (≥150 mGy).
Cumulative dose was associated with brain tumor risk overall, with an excess relative risk (ERR) per 100 mGy of 1.27 (95% CI 0.83-1.77, P<0.001), and with a stronger association for aggressive histologies (ERR per 100 mGy 1.51, 95% CI 1.00-2.11, P<0.001) reported Diana L. Miglioretti, PhD, of the University of California Davis School of Medicine, and colleagues.
"This study adds to the growing evidence that pediatric medical imaging with ionizing radiation is associated with increased cancer risk," they wrote in JAMA.
"These findings reinforce the importance of ensuring that pediatric imaging examinations that use ionizing radiation are ordered only when clinically justified and performed using optimized protocols that minimize dose," they concluded.
Miglioretti and team also noted that the cumulative incidence of brain tumors by age 21 increased from 5.4 per 10,000 children with no exposure to 22.1 per 10,000 children with a cumulative dose of 150 mGy or greater, corresponding to an excess risk of 16.7 brain tumors per 10,000 at that dose level.
For children with cumulative doses of 50 to less than 75 mGy -- a dose range comparable to the dose from one head CT -- the cumulative incidence of brain tumors was 13.3 per 10,000 children, corresponding to an excess risk of 7.9 brain tumors per 10,000 exposed children. The estimated population-attributable fraction of brain tumors associated with radiation exposure from medical imaging was 10.1% (95% CI 5.8-14.2).
In an editorial accompanying the study, Ruggero De Maria, MD, of the Università Cattolica del Sacro Cuore in Rome, and colleagues noted that the study "strengthens an existing epidemiologic signal and makes its potential population impact easier to understand."
However, while these findings "place a rare outcome in perspective," they "should not be used alone when counseling families," they cautioned. "For an individual child, the small potential long-term risk must be considered alongside the often much larger and immediate benefit of obtaining the correct diagnosis."
"For clinical practice, the standard remains straightforward: select the examination most likely to answer the clinical question, use ionizing radiation when its expected benefit justifies the exposure, and obtain the necessary diagnostic information with the lowest dose compatible with adequate image quality," they wrote.
The results from this study support those from other studies, including the European EPI-CT cohort study, which found a significant dose-response relationship, such that for every 10,000 people who received a single head CT scan, approximately one patient developed brain cancer attributable to radiation exposure in the 5 to 15 years following the examination.
However, "these studies were conducted outside North America and therefore reflect CT practices and radiation doses in those settings ... and all focused on radiation exposure from CT rather than cumulative exposure across the full range of medical imaging modalities using ionizing radiation," Miglioretti and colleagues pointed out.
The current study included children born in the U.S. or Ontario, Canada, from 1996 through 2016, and captures imaging histories from birth during a more contemporary era of pediatric imaging. The researchers estimated organ-specific radiation dose from CT, radiography, fluoroscopy, angiography, and nuclear medicine.
A previous analysis of this cohort evaluated hematologic cancer risk and found that up to 10% of blood cancers in children may result from radiation exposure associated with imaging.
The cohort included 3,704,860 children (51.3% male) with 45,671,641 person-years of follow-up (mean follow-up 12.3 years); 82.6% were followed until study end or age 21 years.
A total of 1,536 brain tumors were diagnosed. Of these cases, 55.7% were in males, and 64.5% were diagnosed between the ages of 2 and 10 years. Most tumors (82.5%) were classified as having aggressive histology.
Cumulative dose at the end of follow-up was 1 mGy or greater in 6.8% of all children and 7.9% of those who developed a brain tumor. Overall, 4.4% of all children and 5.9% of those who developed a brain tumor had a cumulative dose of 50 mGy or greater, and 1.1% and 2.3%, respectively, had a cumulative dose of 100 mGy or greater.
Before the end of follow-up, 4.3% of children had one head CT scan, 0.9% had two, and 0.4% had three or more. Among children with a brain tumor, 1.6% had two head CT scans and 1.2% had three or more.
Miglioretti and colleagues acknowledged their study had several limitations, including the fact that it could not account for cancer-predisposing syndromes, and that it did not capture radiation exposure from dental radiographs or cone beam CT.
来源:MedPage Today · medpagetoday.com